More Biotech Events
Join us at a location near you to meet our experts and product specialists, and learn out how the latest technical innovations can improve both the efficiency and quality of your processes at all scales.
October 2019
European Society of Gene Cell Therapy (ESGCT) 27th Annual Congress

Barcelona International Convention Center, Barcelona

The European Society of Gene and Cell Therapy organises its 27th annual congress in Barcelona. The congress brings together scientists working in the fields of gene and cell therapy from throughout Europe and beyond. It is a platform for highlighting the latest research and techniques through the scientific sessions, which include keynote lectures, invited speakers, selected speakers, poster sessions and exhibitions.


Come and meet the Pall Biotech team at booth 66 in theeExhibition area to discuss your projects.

Three scientific posters will be presented:
 

  • Comparison of Static, Suspension and Fixed-Bed Bioreactors to Manufacture Commercial Gene Therapy Products
  • Adherent HEK293T Cells Cultured in Pall’s iCELLis® Nano Bioreactor with OptiPEAK HEK293T Blood-Free Chemically Defined Media Exhibit Robust and Rapid Population Doubling Times
  • Pall Xpansion® Bioreactor Supports Progenitor Cell Growth to >1 Million cells/cm2 and Proper Cell Differentiation


Meet with us at our booth and near our posters during the poster session.

November 2019
Bioproduction Congress 2019

Messe Frankfurt, Frankfurt

Join us on our booth to discover many recent advances in Continuous Bioprocessing, Fluid Control and Single-Use Technologies for a variety of applications in bioprocessing. 

PRESENTATION
November 5
5.00 p.m. to 5.30 p.m.

Downstream Processing Stream
Continuous Bioprocessing: The Alignment of Future Strategies to Industry 4.0
Peter Levison, Executive Director, Business Development


The toolbox of continuous bioprocessing technologies available today offers choices for each unit operation in an end-to-end process providing improved facility utilization, optimized productivity, improved product quality all leading to enhanced patient safety. As we move toward Industry 4.0 we see that automation, control and data management are key aspects of future new continuous bioprocesses. There will be an increased use of virtual reality to design facility layout and optimize equipment usability and digital twins will be used to evaluate various continuous production scenarios and create risk mitigation strategies.


FEATURED PRODUCTS
Allegro™ Single-Use Chromatography System
ARTeSYN Fluid Control Valves
Cadence™ BioSMB PD Multi-column Chromatography System
Kleenpak® Presto Sterile Connectors

Take some time to see us at booth #120D32 and listen to our presentation about continuous bioprocessing. We look forward to meeting you!

December 2019

This page will be updated closer to the event start date. More information about our participation including new technologies, platforms, products and systems will be added in due course.

October 2019
Advanced Therapies: Goals Achieved and New Paths

Novotel Milan Ca' Granda, Milan

Join us during this day of professional growth, discussion and updates on the main trend of Advanced Therapy Medicinal Products.
 

The agenda will cover:

  • Advanced therapies, transplantation and clinical experimentation
  • Spotlight on CAR-T cells 
  • Industry Advances in Advanced Therapies
  • Regulatory aspects in Advanced Therapies


13:30 – 13:45

Presentation: "Accelerator Process Development Services: Your Journey to Industrialization Starts Here"
Marco Sanvito, Senior Regional Marketing Manager, Pall Biotech (Italy)

 

Abstract

The journey to commercializing a therapeutic is a complex and challenging one. It is filled with tasks that include ensuring patient safety, building a product portfolio, working with regulatory agencies, achieving economies of scale on a process typically designed at the academic level, defining a product platform, and addressing fluctuating demands – all while keeping down costs. With the ever-shrinking pool of resources and technical expertise, these can be daunting tasks to achieve. At Pall, we understand the issues you are facing, and while we may not be able to solve all your journey’s challenges, what we can do is help to minimize the risk. We deliver a robust, reproducible and scalable process that helps you move beyond laboratory scale process choices to those that are proven to support industrialized processes. Using our global centers of excellence and our industry leading technology, we specialize in designing, optimizing and transferring scalable processes from pre-clinical to validated cGMP manufacturing.



Take some time to see us at presenter sessions throughout the event. We look forward to meeting you!